A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I

Although the number of human T-cell leukemia virus type-I (HTLV-I)-infected individuals in the world has been estimated at over 10 million, no prophylaxis vaccines against HTLV-I infection are available. In this study, we took a new approach for establishing the basis of protective vaccines against...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Hideki, Shimizu, Mamoru, Miyagi, Takuya, Kunihiro, Marie, Tanaka, Reiko, Takahashi, Yoshiaki, Tanaka, Yuetsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776196/
https://www.ncbi.nlm.nih.gov/pubmed/26848684
http://dx.doi.org/10.3390/v8020041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776196/
https://www.ncbi.nlm.nih.gov/pubmed/26848684
http://dx.doi.org/10.3390/v8020041

Ejemplares similares